Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures

Journal of Process Control

Volumn 17, Issue 3, 2007, Pages 253-260

  Xia, Xiaohua ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Biomedical; HIV AIDS; Identifiability; Identification; Nonlinear systems

Indexed keywords

BIOMEDICAL ENGINEERING; DRUG PRODUCTS; NONLINEAR SYSTEMS; PARAMETER ESTIMATION; PATIENT TREATMENT; VACCINES;

DRUG EFFECTIVENESS; HIV/AIDS; IDENTIFIABILITY;

DISEASES;

EID: 33846828381     PISSN: 09591524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprocont.2006.10.007     Document Type: Article

References (39)

1. Callaway D.S., and Perelson A.S. HIV-1 infection and low steady-state viral loads. Bulletin of Mathematical Biology 64 (2002) 29-64
2. Chun T.W., Carruth L., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387 (1997) 183-188
3. Cocho G., Huerta L., et al. A multiple compartment model for the evolution of HIV-1 after highly active antiretroviral therapy, Mathematical Approaches for Emerging and Reemerging Infectious Diseases: an Introduction (Minneapolis, MN, 1999). IMA Journal of Mathematics Applied in Medicine and Biology Vol.125 (2002), Springer, New York 309-323
4. Covert D., and Kirschner D. Revisiting early models of the host-pathogen interactions in HIV infection. Comments Theoretical Biology 5 (2000) 383-411
5. Craig I., and Xia X. Can HIV/AIDS be controlled?. IEEE Control Systems Magazine 25 (2005) 80-83
6. Craig I., Xia X., and Venter J.W. Introducing HIV/AIDS education into the electrical engineering curriculum at the University of Pretoria. IEEE Transactions on Education 47 (2004) 65-73
7. Dewhurst S., da Cruz R.L.W., and Whetter L. Pathogenesis and treatment of HIV-1 infection: recent developments (Y2K update). Frontiers in Bioscience 5 (2000) 30-49
8. Fauci A.S., Pantaleo G., Stanley S., and Weissman D. Immunopathogenic mechanisms of HIV infection. Annals of Internal Medicine 124 (1996) 654-663
9. Filter R., and Xia X. A penalty function approach to HIV/AIDS model parameter estimation. Proceedings of the 13th IFAC Symposium on System Identification (2003), Rotterdam, The Netherlands August 27-29
10. Filter R., Xia X., and Gray C. Dynamic HIV/AIDS parameter estimation with application to a vaccine readiness study in Southern Africa. IEEE Transactions on Biomedical Engineering 52 (2003) 284-291
11. Gray C., Williamson C., Bredell H., Puren A., Xia X., et al. Viral dynamics and CD4+ T-cell counts in subtype C human immunodeficiency virus type-1 -infected individuals from southern Africa. Aids Research and Human Retroviruses 21 (2005) 285-291
12. Grossman Z., Polis M., et al. Ongoing dissemination during HAART. Nature Medicine 5 (1999) 1099-1104
13. Haase A.T., Henry K., et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274 (1996) 985-989
14. Ho D.D., Neumann A.U., et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 273 (1995) 123-126
15. Janeway C.A., and Travers P. Immunobiology: The Immune System in Health and Disease (1997), Garland, New York
16. M. Jeffrey, X. Xia, Identifiability of HIV/AIDS models, in: H. Wu and W.Y. Tan (Eds.), Deterministic and Stochastic Models of AIDS and HIV with Intervention, World Scientific Publications, Singapore (Chapter 11).
17. M. Jeffrey, X. Xia, I. Craig, Identifiability of an extended HIV model, in: Proceedings of the 5th IFAC Symposium on Modelling and Control in Biomedical System, Melbourne, Australia, August 21-23, 2003.
18. Kirschner D., Webb G.F., and Cloyd M. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lyphocytes. JAIDS 24 (2000) 352-362
19. Klenerman P., Phillips R.E., et al. Cytotoxic T-lymphocytes and viral turnover in HIV type-1 infection. Proceedings of the National Academic Science USA 93 (1996) 15323-15328
20. Mellors J.W., Rinaldo C.R., et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996) 1167-1170
21. Mellors J.W., Munoz A., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine 126 (1997) 946-954
22. Nowak M.A., and Bangham C.R.M. Population dynamics of immune responses to persistent viruses. Science 272 (1996) 74-79
23. Nowak M.A., and Bonhoeffer S. Scientific correspondence. Science 375 (1995) 193
24. Nowak M.A., and May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology (2000), Oxford University Press, New York
25. Nowak M.A., May R.M., and Sigmund K. Immune-responses against multiple epitopes. Journal of Theoretical Biology 175 (1995) 325-353
26. D.A. Ouattara, Mathematical analysis of the HIV-1 infection: parameter estimation, therapies effectiveness and therapeutical failures, in: Proceedings of the 27th IEEE EMBS Annual International Conference, September 1-4, 2005, Shanghai, China.
27. Ouattara D.A., Bugnon F., Raffi F., and Moog C.H. Parameter identification of an HIV/AIDS model. Proceedings of the 13th International Symposium on HIV and Emerging Infectious Diseases (2004), Toulon, France September
28. A. S. Perelson, P. Essunger, M. Markowitz, D. D. Ho, How long should treatment be given if we had an antiretroviral regimen that completely blocked HIV replication?, in: Proceedings of the XIth International Conference on AIDS.
29. Perelson A.S., Essunger P., et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387 (1997) 188-191
30. Perelson A.S., and Nelson P.W. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Review 41 (1999) 3-44
31. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 (1996) 1582-1586
32. Schacker T.W., Hughes J.P., et al. Biological and virologic characteristics of primary HIV infection. Annals of Internal Medicine 128 (1998) 613-620
33. Schuurman R., Descamps D., et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology 34 (1996) 3016-3022
34. + T-cells by HIV and some Monte Carlo studies. Mathematical Biosciences 147 (1998) 173-205
35. USPHS, Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. HIV/AIDS Treatment Information Service, 2003, http://www.aidsinfo.nih.gov.
36. Wei X., Ghosh S.K., et al. Viral dynamics in HIV-1 infection. Nature 273 (1995) 112-117
37. Wu H., and Tan W.Y. Deterministic and Stochastic Models of AIDS and HIV with Intervention (2005), World Scientific, Publications, Singapore
38. Xia X. Estimation of HIV/AIDS parameters. Automatica 39 (2003) 1983-1988
39. Xia X., and Moog C.H. Identifiability of nonlinear systems with application to HIV/AIDS models. IEEE Transactions on Automatic Control 48 (2003) 330-336